225 related articles for article (PubMed ID: 2113492)
1. Evaluation of leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins for in vitro fertilization or gamete intrafallopian transfer.
Ferrier A; Rasweiler JJ; Bedford JM; Prey K; Berkeley AS
Fertil Steril; 1990 Jul; 54(1):90-5. PubMed ID: 2113492
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
[TBL] [Abstract][Full Text] [Related]
3. Randomized, prospective trial of leuprolide acetate and conventional superovulation in first cycles of in vitro fertilization and gamete intrafallopian transfer.
Kubik CJ; Guzick DS; Berga SL; Zeleznik AJ
Fertil Steril; 1990 Nov; 54(5):836-41. PubMed ID: 2121551
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant leuprolide in normal, abnormal, and poor responders to controlled ovarian hyperstimulation for in vitro fertilization/gamete intrafallopian transfer.
Sathanandan M; Warnes GM; Kirby CA; Petrucco OM; Matthews CD
Fertil Steril; 1989 Jun; 51(6):998-1006. PubMed ID: 2498135
[TBL] [Abstract][Full Text] [Related]
5. The relative success of gonadotropin-releasing hormone analogue, clomiphene citrate, and gonadotropin in 1,099 cycles of in vitro fertilization.
Dor J; Ben-Shlomo I; Levran D; Rudak E; Yunish M; Mashiach S
Fertil Steril; 1992 Nov; 58(5):986-90. PubMed ID: 1426387
[TBL] [Abstract][Full Text] [Related]
6. Pituitary down-regulation using leuprolide for the intensive ovulation management of poor prognosis patients having in vitro fertilization (IVF)-related treatments.
Cummins JM; Yovich JM; Edirisinghe WR; Yovich JL
J In Vitro Fert Embryo Transf; 1989 Dec; 6(6):345-52. PubMed ID: 2517507
[TBL] [Abstract][Full Text] [Related]
7. Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins in 408 first cycles of in vitro fertilization.
Tummon IS; Daniel SA; Kaplan BR; Nisker JA; Yuzpe AA
Fertil Steril; 1992 Sep; 58(3):563-8. PubMed ID: 1521653
[TBL] [Abstract][Full Text] [Related]
8. Leuprolide acetate-prepared in vitro fertilization-gamete intrafallopian transfer cycles: efficacy versus controls and cost analysis.
Corson SL; Batzer FR; Gocial B; Eisenberg E; Huppert LC; Nelson JR
Fertil Steril; 1992 Mar; 57(3):601-5. PubMed ID: 1740205
[TBL] [Abstract][Full Text] [Related]
9. Effects of clomiphene citrate and leuprolide acetate on luteal-phase hyperprolactinemia during ovarian stimulation with menopausal gonadotropins.
Kaplan CR; Koong MK; Olive DL; Riehl RM; Burns WN; Groff TR; Schenken RS
J In Vitro Fert Embryo Transf; 1991 Dec; 8(6):308-13. PubMed ID: 1770270
[TBL] [Abstract][Full Text] [Related]
10. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization.
Garcia JE; Padilla SL; Bayati J; Baramki TA
Fertil Steril; 1990 Feb; 53(2):302-5. PubMed ID: 2105247
[TBL] [Abstract][Full Text] [Related]
11. Comparison of intermittent and continuous use of a gonadotropin-releasing hormone antagonist (Nal-Glu) in in vitro fertilization cycles: a preliminary report.
Cassidenti DL; Sauer MV; Paulson RJ; Ditkoff EC; Rivier J; Yen SS; Lobo RA
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 1):1806-10. PubMed ID: 1750479
[TBL] [Abstract][Full Text] [Related]
12. Clomiphene citrate and hMG: an alternative stimulation protocol for selected failed in vitro fertilization patients.
Benadiva CA; Davis O; Kligman I; Liu HC; Rosenwaks Z
J Assist Reprod Genet; 1995 Jan; 12(1):8-12. PubMed ID: 7580013
[TBL] [Abstract][Full Text] [Related]
13. Ovarian response and pregnancy rates in in vitro fertilization, gamete intrafallopian transfer, and in vivo fertilization therapies after combined gonadotropin-releasing hormone agonist/human menopausal gonadotropin stimulation.
Lindner C; Braendle W; Lichtenberg V; Köhler S; Bettendorf G
Gynecol Obstet Invest; 1990; 29(2):140-4. PubMed ID: 2139861
[TBL] [Abstract][Full Text] [Related]
14. Luteal phase consequences of low-dose gonadotropin-releasing hormone agonist therapy in nonluteal-supported in vitro fertilization cycles.
Long CA; Sopelak VM; Lincoln SR; Cowan BD
Fertil Steril; 1995 Sep; 64(3):573-6. PubMed ID: 7641913
[TBL] [Abstract][Full Text] [Related]
15. Follicular stimulation for in vitro fertilization using pituitary suppression and human menopausal gonadotropins.
Awadalla SG; Friedman CI; Chin NW; Dodds W; Park JM; Kim MH
Fertil Steril; 1987 Nov; 48(5):811-5. PubMed ID: 3117593
[TBL] [Abstract][Full Text] [Related]
16. WITHDRAWN: Gonadotrophin-releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles.
Daya S
Cochrane Database Syst Rev; 2007 Jul; (1):CD001299. PubMed ID: 17636664
[TBL] [Abstract][Full Text] [Related]
17. Ovulation stimulation and induction.
Blacker CM
Endocrinol Metab Clin North Am; 1992 Mar; 21(1):57-84. PubMed ID: 1576983
[TBL] [Abstract][Full Text] [Related]
18. The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles.
Kerin JF
Arch Gynecol Obstet; 1989; 246 Suppl():S45-52. PubMed ID: 2511810
[No Abstract] [Full Text] [Related]
19. Implantation, abortion, and birth after in vitro fertilization using the natural menstrual cycle or follicular stimulation with clomiphene citrate and human menopausal gonadotropin.
Fishel SB; Edwards RG; Purdy JM; Steptoe PC; Webster J; Walters E; Cohen J; Fehilly C; Hewitt J; Rowland G
J In Vitro Fert Embryo Transf; 1985 Sep; 2(3):123-31. PubMed ID: 3932567
[TBL] [Abstract][Full Text] [Related]
20. Opposite responses to the addition of leuprolide acetate to human menopausal gonadotropin therapy in two perimenopausal women.
Check JH; Adelson HG
Int J Fertil; 1990; 35(6):343-6. PubMed ID: 1981209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
